Pharma Bio Serv Stock Current Valuation
| PBSV Stock | USD 0.53 0.03 6.00% |
Valuation analysis of Pharma Bio Serv helps investors to measure Pharma-Bio Serv's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Pharma-Bio Serv's price fluctuation is out of control at this time. Calculation of the real value of Pharma Bio Serv is based on 3 months time horizon. Increasing Pharma-Bio Serv's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pharma-Bio otc stock is determined by what a typical buyer is willing to pay for full or partial control of Pharma Bio Serv. Since Pharma-Bio Serv is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pharma-Bio OTC Stock. However, Pharma-Bio Serv's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.53 | Real 0.46 | Hype 0.53 | Naive 0.51 |
The intrinsic value of Pharma-Bio Serv's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pharma-Bio Serv's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pharma Bio Serv helps investors to forecast how Pharma-Bio otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharma-Bio Serv more accurately as focusing exclusively on Pharma-Bio Serv's fundamentals will not take into account other important factors: Pharma Bio Serv OTC Stock Current Valuation Analysis
Pharma-Bio Serv's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Pharma-Bio Serv Current Valuation | 4.87 M |
Most of Pharma-Bio Serv's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharma Bio Serv is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Pharma Bio Serv has a Current Valuation of 4.87 M. This is 99.97% lower than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.97% higher than that of the company.
Pharma-Bio Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharma-Bio Serv's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Pharma-Bio Serv could also be used in its relative valuation, which is a method of valuing Pharma-Bio Serv by comparing valuation metrics of similar companies.Pharma Bio is currently under evaluation in current valuation category among its peers.
Pharma-Bio Fundamentals
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 4.87 M | |||
| Shares Outstanding | 22.95 M | |||
| Shares Owned By Insiders | 64.53 % | |||
| Price To Earning | 10.00 X | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 0.90 X | |||
| Revenue | 19.4 M | |||
| Gross Profit | 4.88 M | |||
| EBITDA | 1.23 M | |||
| Net Income | 1.01 M | |||
| Cash And Equivalents | 14.24 M | |||
| Cash Per Share | 0.62 X | |||
| Total Debt | 520.77 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 9.07 X | |||
| Book Value Per Share | 0.72 X | |||
| Cash Flow From Operations | 592.46 K | |||
| Earnings Per Share | 0.04 X | |||
| Target Price | 1.77 | |||
| Number Of Employees | 140 | |||
| Beta | 0.36 | |||
| Market Capitalization | 20.88 M | |||
| Total Asset | 20.65 M | |||
| Retained Earnings | 20.5 M | |||
| Working Capital | 20.6 M | |||
| Current Asset | 22.27 M | |||
| Current Liabilities | 1.67 M | |||
| Z Score | 24.0 | |||
| Annual Yield | 0.06 % | |||
| Net Asset | 20.65 M |
About Pharma-Bio Serv Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharma Bio Serv's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharma-Bio Serv using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharma Bio Serv based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharma-Bio OTC Stock Analysis
When running Pharma-Bio Serv's price analysis, check to measure Pharma-Bio Serv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma-Bio Serv is operating at the current time. Most of Pharma-Bio Serv's value examination focuses on studying past and present price action to predict the probability of Pharma-Bio Serv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma-Bio Serv's price. Additionally, you may evaluate how the addition of Pharma-Bio Serv to your portfolios can decrease your overall portfolio volatility.